Pharmacists can identify barriers to medication adherence by examining the factors that affect a patient’s ability to take their medications. These barriers may be complex and include factors such as socioeconomics, health care system structures and processes, severity of comorbidities, complexity of medication and nonmedication therapies, and patient concerns. Pharmacists can then employ shared decision-making approaches to help patients eliminate or manage these barriers.5
Providing Health and Wellness Services
Pharmacists can provide several health and wellness services, including health screening, chronic disease state management, immunization, COVID-19 testing, and medication therapy management (MTM). In some cases, pharmacists can write prescriptions for needs such as contraception and some test-and-treat programs.
Performing MTM Services
MTM is a systematic process of obtaining patient-specific information regarding medication therapies to identify medication-related problems and create a plan to resolve them. Medication therapy reviews can be comprehensive or targeted to a specific medication-related challenge. Whether comprehensive or targeted, the patient’s medications are evaluated in the context of the patient, taking into consideration all their conditions and therapies.6
Assessing Patient Health Status
Patient assessment is essential to identify drug-related problems, monitor or manage patients requiring chronic drug therapy, and enable the pharmacist to diagnose and treat common minor acute illnesses. Assessment also allows pharmacists to appropriately refer patients who
require a higher level of care and enhances the pharmacist’s ability to educate patients about their disease, its presentation, complications, and management. Because communication among health professionals is often based on the patient assessment process, it enables the pharmacist to communicate with other providers more effectively.7
Coordinating Care Transitions
Pharmacists can tailor complex transition interventions to individual patients, including comprehensive medication review, patient counseling, and direct collaboration with providers. Challenges include identifying patients at high risk, establishing cost-effective strategies, and creating methods to increase the potential impact of these interventions.8
Preventing Drug Diversion
The American Society of Health-System Pharmacists recommends a framework for preventing drug diversion driven by 4 key principles. These principles center on creating a collaborative approach, establishing clear processes for accountability and responsibility, implementing standard processes, and encouraging an overall culture of continuous readiness and quality improvement.9
Advancing Medication Stewardship
Antibiotic stewardship programs have been effective at improving outcomes, reducing adverse events, and reducing antibiotic resistance. Given the success of the antibiotic stewardship model, pharmacist involvement in other medication stewardship programs may increase. Pharmacists offer a unique skill set to advance pain and opioid stewardship programs as well as other therapeutic areas such as glycemic control and thrombotics.10
References
1. Drug assistance program. Asthma and Allergy Foundation of America. Updated January 2024. Accessed April 14, 2024. https://aafa.org/advocacy/advocacy-resources/patient-assistance-medicine-drug-programs/
2. Eze UIH, Fasanya MO, Babalola OC, Onwuchuluba E, Ajayi AI, Eze AG. Patients’ perceptions of medication counseling and education provided by pharmacists. Am J Pharmaco Pharmac Sci. 2023;2:9. doi:10.25259/AJPPS_2023_009
3. Bian J, Li Q, Li J, et al. Guideline for the evaluation of prescription appropriateness. Ann Transl Med. 2021;9(16):1352. doi:10.21037/atm-20-7502
4. Medicines adherence. Royal Pharmaceutical Society. Accessed April 14, 2024. https://www.rpharms.com/resources/pharmacy-guides/medicines-adherence
5. Tailored pharmacy-based interventions to improve medication adherence. CDC. February 24, 2023. Accessed April 14, 2024. https://www.cdc.gov/dhdsp/pubs/medication-adherence.htmMedicationmanagement.
6. American Pharmacists Association. Accessed April 14, 2024. https://www.pharmacist.com/Practice/Patient-Care-Services/Medication-Management
7. Herrier RN, Apgar DA, Boyce RW, Foster SL. Introduction to patient assessment for pharmacists. In: Patient Assessment in Pharmacy. McGraw-Hill Education; 2015.
8. Slazak E, Cardinal C, Will S, Clark CM, Daly CJ, Jacobs DM. Pharmacist-led transitions-of-care services in primary care setting: Opportunities, experiences, and challenges. J Am Pharm Assoc (2003). 2020;60(3):443-449. doi:10.1016/j.japh.2019.11.016
9. Clark J, Fera T, Fortier C, et al. ASHP guidelines on preventing diversion of controlled substances. Am J Health Syst Pharm. 2022;79(24):2279-2306. doi:10.1093/ajhp/zxac246
10. Dopp AL, Hall KK, Fitall E. Pharmacist role in patient safety. Patient Safety Network. February 21, 2020. Accessed April 14, 2024. https://psnet.ahrq.gov/perspective/pharmacist-role-patient-safety